Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries.
Peter Ueda,
Björn Pasternak,
Björn Eliasson,
Ann-Marie Svensson,
Stefan Franzén,
Soffia Gudbjörnsdottir,
Kristian Hveem,
Christian Jonasson,
Mads Melbye,
Henrik Svanström